WELCOME TO The HEALTHCARE REPORT
Access Rehab Equipment
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
SymphonyCare | January 13, 2021
SymphonyCare, a leading provider of clinical and cases data arrangements, today reported the accessibility of WellStack™, an advanced healthcare data environment and large data analytics stage, in the Microsoft Azure Marketplace, an online store giving applications and administrations to use on Microsoft Azure. SymphonyCare clients exploit the adaptability, dependability, and HITRUST security of Azure, with smooth...
Canon Medical Systems USA | November 28, 2022
Canon Inc. announced that the company has decided to establish a new subsidiary, to be named Canon Healthcare USA, INC. By strengthening its presence in the highly influential American medical market, Canon aims to accelerate the growth of its medical business.
The Canon group is currently working towards a grand strategic transformation of its business portfolio in order to realize future growth. With the announcement of Phase VI, the latest in the company’s Excellent Global ...
MedCity News | January 14, 2020
Digital health companies have caught the eye of prominent corporate VCs. But funding rounds aside, they’ve still struggled to gain traction in a risk-averse industry. Audience members at a panel during J.P. Morgan Healthcare asked, will it take a marriage of the technology and pharmaceutical industries for them to succeed? So many companies today aren’t just life science companies or technology companies. They’re some combination of the two, said Stacy Feld, head of Johns...
Roche | March 28, 2022
Roche announced that it has entered into a collaboration with Bristol Myers Squibb to support the advancement of two assays for use in clinical trials with the development and deployment of two new digital pathology algorithms.
In the first project under this collaboration, Roche Digital Pathology is creating an AI-based image analysis algorithm to aid pathologists in interpreting the on-market VENTANA PD-L1 (SP142) Assay. Bristol Myers Squibb will use this algorithm to generate bio...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE